» Articles » PMID: 25216337

Environmental Factors, Toxicants and Systemic Lupus Erythematosus

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2014 Sep 13
PMID 25216337
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is an immune-complex-mediated multi-systemic autoimmune condition of multifactorial etiology, which mainly affects young women. It is currently believed that the onset of SLE and lupus flares are triggered by various environmental factors in genetically susceptible individuals. Various environmental agents and toxicants, such as cigarette smoke, alcohol, occupationally- and non-occupationally-related chemicals, ultraviolet light, infections, sex hormones and certain medications and vaccines, have been implicated to induce SLE onset or flares in a number case series, case-control and population-based cohort studies and very few randomized controlled trials. Here, we will describe some of these recognized environmental lupus triggering and perpetuating factors and explain how these factors potentially bias the immune system towards autoimmunity through their interactions with genetic and epigenetic alterations. Further in-depth exploration of how potentially important environmental factors mechanistically interact with the immune system and the genome, which trigger the onset of SLE and lupus flares, will certainly be one of the plausible steps to prevent the onset and to decelerate the progress of the disease.

Citing Articles

Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases.

Nikpour M, Morrisroe K, Calderone A, Yates D, Silman A Nat Rev Rheumatol. 2025; 21(3):137-156.

PMID: 39910253 DOI: 10.1038/s41584-024-01216-3.


The 330 risk loci known for systemic lupus erythematosus (SLE): a review.

Laurynenka V, Harley J Front Lupus. 2024; 2.

PMID: 39624492 PMC: 11609870. DOI: 10.3389/flupu.2024.1398035.


Cryptogenic Organizing Pneumonia Is Associated With Increased Mortality Risk in Hospitalizations for Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis.

Uwumiro F, Emmanuel A, Offiah C, Umeani N, Ozigbo A, Idahor C Cureus. 2024; 16(9):e69901.

PMID: 39439634 PMC: 11494845. DOI: 10.7759/cureus.69901.


Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus.

Samavati S, Yarani R, Kiani S, Hoseinkhani Z, Mehrabi M, Levitte S J Inflamm (Lond). 2024; 21(1):20.

PMID: 38867277 PMC: 11170788. DOI: 10.1186/s12950-024-00381-2.


Exposure to Environmental Toxins & Autoimmune Conditions.

Kharrazian D Integr Med (Encinitas). 2024; 23(1):22-26.

PMID: 38618165 PMC: 11007618.


References
1.
Wang J, Kay A, Fletcher J, Formica M, McAlindon T . Is lipstick associated with the development of systemic lupus erythematosus (SLE)?. Clin Rheumatol. 2008; 27(9):1183-7. PMC: 3645843. DOI: 10.1007/s10067-008-0937-6. View

2.
Sinniah R, Feng P . Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clin Nephrol. 1976; 6(2):340-51. View

3.
Basu D, Liu Y, Wu A, Yarlagadda S, Gorelik G, Kaplan M . Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol. 2009; 183(5):3481-7. PMC: 2730421. DOI: 10.4049/jimmunol.0900034. View

4.
Gilbert E, Mathis K, Ryan M . 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus. Hypertension. 2013; 63(3):616-23. PMC: 4365871. DOI: 10.1161/HYPERTENSIONAHA.113.02385. View

5.
Shoenfeld Y, Aron-Maor A . Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun. 2000; 14(1):1-10. DOI: 10.1006/jaut.1999.0346. View